Agios Pharmaceuticals (AGIO) Treasury Shares (2012 - 2026)

Agios Pharmaceuticals has reported Treasury Shares for 6 years, with the latest figure at $802.5 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares changed 0.0% year-over-year to $802.5 million; the trailing twelve-month figure through Mar 2026 stood at $802.5 million (changed 0.0% YoY), and the FY2025 full-year result was $802.5 million, changed 0.0% from the prior year.
• Treasury Shares for Q1 2026 stood at $802.5 million, roughly flat from $802.5 million in the prior quarter.
• The five-year high for Treasury Shares was $16.2 billion in Q1 2022, with the low at $16.2 million in Q4 2022.
• Historically, Treasury Shares has averaged $10.5 billion across 5 years, with a median of $16.2 billion in 2022.
• The largest YoY upside for Treasury Shares was 51.69% in 2022 against a maximum downside of 0.0% in 2022.
• Agios Pharmaceuticals' Treasury Shares stood at $802.5 million in 2022, then changed by 0.0% to $802.5 million in 2023, then changed by 0.0% to $802.5 million in 2024, then changed by 0.0% to $802.5 million in 2025, then changed by 0.0% to $802.5 million in 2026.
• The last three Treasury Shares figures came in at $802.5 million (Q1 2026), $802.5 million (Q4 2025), and $802.5 million (Q3 2025), per Business Quant data.